Clinical trial
Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access…
NCT00096811 · Bristol-Myers Squibb, Industry · No longer available
Key facts
| NCT number | NCT00096811 |
|---|---|
| Title | Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program |
| Official title | A Treatment Use Protocol of Entecavir in Subjects With Chronic Hepatitis B Infection Who Have Failed or Who Are Intolerant of Available Therapies |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | No longer available |
| Study type | Expanded Access |
| Conditions | Hepatitis B, Chronic Disease |
| Intervention type | Drug |
| Interventions | Entecavir |
| Start date | Sep 1, 2003 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Nov 16, 2004 |
| Last update posted | Sep 21, 2016 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: